News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
188
Sources here
21
Companies here
7
Search results Stored financial headlines

Active search

188 matching headlines

Ticker or company: GAINMain company stories
Clear
Latest

Stock Traders Daily Market update

Discipline and Rules-Based Execution in GAINZ Response

This article provides an analysis of Gladstone Investment Corporation 4.875% Notes Due 2028 (NASDAQ: GAINZ), noting a neutral sentiment and a mid-channel oscillation pattern. It outlines three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop loss points. The analysis also includes multi-timeframe signal analysis, showing neutral signals across near-term, mid-term, and long-term horizons.

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of "Moderate Buy" by Analysts

Gain Therapeutics (NASDAQ:GANX) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $7.50. The company recently reported a narrower-than-expected quarterly loss of $0.11 per share. Institutional investors hold a significant portion of GANX stock, with several firms …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(GAINN) Risk Channels and Responsive Allocation

This article from Stock Traders Daily discusses "Risk Channels and Responsive Allocation" for Gladstone Investment Corporation 5.00% Notes Due 2026 (NASDAQ: GAINN). It highlights key findings and AI-generated institutional trading strategies, including position trading, momentum breakout, and risk hedging strategies. The content emphasizes real-time …

GAIN main company
Sharemaestro market context Trend signal active 52 weeks +22.2% GAIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Q3 EPS Estimates for Airgain Boosted by Northland Securities

Northland Securities has increased its Q3 2026 EPS estimate for Airgain (NASDAQ:AIRG) to $0.00 from a previous forecast of a $0.04 loss per share, following the company's recent beat on quarterly EPS and revenue. The firm also provided FY2026 and FY2027 EPS projections. Airgain's …

AIRG main company
Sharemaestro market context Price below Trend Line 52 weeks +27.3% · Next-week setup negative 44.5% AIRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kayne Anderson Rudnick (NASDAQ: OLLI) reports 1.6% beneficial stake in Ollie’s

Kayne Anderson Rudnick Investment Management, LLC has filed an amended beneficial ownership report for Ollie's Bargain Outlet Holdings Inc (OLLI), disclosing a 1.6% beneficial stake. The firm owns 974,819 shares of common stock as of June 30, 2026, with detailed allocations for sole and …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

eGain Says AI Knowledge ARR Grew 26% as Enterprise AI Demand Builds

eGain (NASDAQ: EGAN) reported that its AI Knowledge Annual Recurring Revenue (ARR) increased by 26% year-over-year, now comprising two-thirds of its total SaaS ARR through Q3 fiscal 2026. This growth is driven by rising enterprise demand for governed AI knowledge systems, especially in regulated …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BTIG Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $5

BTIG has reiterated its Buy rating on Gain Therapeutics (GANX.US) and maintained its price target of $5. This indicates a continued positive outlook from the firm regarding the company's stock performance.

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

eGain Wins Two Bronze Stevie Awards® in 2026 International Business Awards®

eGain (NASDAQ: EGAN) has won two Bronze Stevie Awards in the 23rd Annual International Business Awards. The company was recognized for its AI Knowledge Hub in the "AI for Customer Experience" category and eGain Composer in the "Customer Service Innovation of the Year" category. …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

eGain Wins Two Bronze Stevie Awards for AI Knowledge Hub and Composer in 2026 International Business Awards

eGain (NASDAQ: EGAN) has won two Bronze Stevie Awards in the 23rd Annual International Business Awards. The company was recognized for its AI Knowledge Hub in the "AI for Customer Experience" category and eGain Composer in the "Customer Service Innovation of the Year" category. …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BTIG Research Reaffirms Buy Rating for Gain Therapeutics (NASDAQ:GANX)

BTIG Research has reaffirmed its Buy rating for Gain Therapeutics (NASDAQ:GANX), setting a $5.00 price target, which suggests a 142.72% upside. The company reported a quarterly loss of $0.11 per share, outperforming consensus estimates. Institutional investors currently hold 11.97% of Gain Therapeutics' stock.

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics, Inc. Q2 2026: Net loss $4.7M, EPS $(0.11) — 10-Q Summary

Gain Therapeutics, Inc. reported a net loss of $4.7M for Q2 2026, an improvement from $5.8M in the prior year, with diluted EPS at $(0.11) compared to $(0.19) in Q2 2025. The company remains pre-revenue, but advanced its clinical pipeline with an FDA-authorized IND …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

eGain Corp (EGAN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for eGain Corp (EGAN), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 3 analysts, the stock has an average target price of $17.50, with a "Hold" signal trend. The article also includes …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Budget-friendly retailers Ollie’s, Marshalls plan new NJ locations

Budget-friendly retailers Ollie’s Bargain Outlet and Marshalls are set to open new stores in New Jersey ahead of the back-to-school shopping season, catering to consumers looking for value amidst expected price increases. Ollie's will open in Clementon on August 12, offering discounted merchandise, while …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics (NASDAQ:GANX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Gain Therapeutics (NASDAQ:GANX) announced its quarterly earnings, reporting a loss of $0.11 per share, which surpassed the consensus estimate of a $0.14 loss by $0.03. Following the announcement, the company's shares increased to $1.92, contributing to its $81.76 million market capitalization. Analysts maintain a …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unigarant selects eGain for AI knowledge management platform

Unigarant, a Dutch insurance company and subsidiary of ANWB, has chosen eGain's AI Knowledge Hub to modernize its enterprise knowledge management. The platform aims to enhance advisor and claims handler productivity, improve service delivery across various channels, and establish a trusted knowledge foundation for …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Ollie’s (OLLI) Rising Price-Conscious Customer Base Quietly Reshaping Its Long-Term Value Story?

Ollie's Bargain Outlet's recent survey indicates that inflation is driving more price-conscious consumers to discount retailers, strengthening Ollie's position as a value destination. While this supports near-term demand, the primary risk remains the consistency and quality of closeout inventory. The article suggests investors consider …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

Gain Therapeutics (Nasdaq: GANX) announced its Q2 2026 financial results and a corporate update, highlighting FDA authorization of its IND for rexaceract, paving the way for Phase 2 clinical development for Parkinson's disease. The company reported continued positive results from its Phase 1b study, …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Technology Credit Union Selects eGain AI Knowledge Hub to Enhance Member and Employee Experience

Technology Credit Union (Tech CU) has chosen eGain AI Knowledge Hub to modernize its member service and create a governed, AI-ready knowledge foundation across its enterprise. This selection aims to improve the speed and quality of member service and provide employees with easy access …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(GAIN) and the Role of Price-Sensitive Allocations

This article provides an analysis of Gladstone Investment Corporation (NASDAQ: GAIN), highlighting neutral near and mid-term readings but a strong long-term positive bias. It details an exceptional risk-reward setup targeting a 7.0% gain with minimal risk and outlines three distinct AI-generated trading strategies for …

GAIN main company
Sharemaestro market context Trend signal active 52 weeks +22.2% GAIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ollie’s Bargain Outlet kicks off National Bargain Hunting Week

Ollie's Bargain Outlet is launching its National Bargain Hunting Week by releasing a survey that indicates inflation is significantly impacting consumer shopping habits. The survey of nearly 60,000 loyalty members shows that a large majority are concerned about rising prices and are increasingly seeking …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ollie's Celebrates National Bargain Hunting Week with New Shopper Survey

Nearly 60,000 Shoppers Reveal Why Good Stuff Cheap® Matters HARRISBURG, Pa., Aug. 10, 2026 /PRNewswire/ -- Ollie's Bargain Outlet Holdings, Inc., America's fastest growing retailer of brand name closeouts and excess inventory, celebrates the kickoff of National Bargain Hunting Week today with new shopper …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics Inc (GANX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Gain Therapeutics Inc (GANX), highlighting its current earnings forecast score of 8.80, ranking 54th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $7.00, with a consensus of "Buy" based on …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Airgain, Inc. (NASDAQ:AIRG) Receives Average Rating of "Moderate Buy" from Brokerages

Airgain, Inc. (NASDAQ:AIRG) has received a consensus "Moderate Buy" rating from five brokerages, with an average 12-month price target of $7.70, exceeding its current share price of $5.53. Despite reporting quarterly earnings of $0.02 EPS and revenue of $13.70 million (beating consensus estimates), the …

AIRG main company
Sharemaestro market context Price below Trend Line 52 weeks +27.3% · Next-week setup negative 44.5% AIRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gladstone Investment (NASDAQ:GAIN) Announces Earnings Results, Beats Estimates By $0.04 EPS

Gladstone Investment (NASDAQ:GAIN) announced quarterly earnings of $0.26 per share, surpassing analyst estimates by $0.04, with revenues of $28.36 million also exceeding expectations. The company declared a monthly dividend of $0.08 per share, representing an annualized yield of approximately 5.8%. Despite a positive financial …

GAIN main company
Sharemaestro market context Trend signal active 52 weeks +22.2% GAIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Gain Therapeutics Inc (GANX) is projected to report a loss of 14 cents per share. This information comes from a Reuters earnings preview available on TradingView News.

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gain Therapeutics Inc (GANX) Stock News Today

This page provides current news and financial data for Gain Therapeutics Inc (GANX). As of August 7th, the stock closed at $1.82, up 2.25%, with an after-hours price of $1.78 on August 10th. The platform indicates that more news will be coming soon for …

GANX main company
Sharemaestro market context Price above Trend Line 52 weeks +7.6% · Next-week setup negative 40.3% GANX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gladstone Investment aims to deploy at least $116M in first 6 months as SFEG exit advances

Earnings Call Insights: Gladstone Investment (GAIN) Q1 2027 MANAGEMENT VIEW * “GAIN again produced solid quarter results this time for this first quarter ended June 30, 2026. We generated adjusted NII of $0.26 per share… and we also ended a total portfolio fair value …

GAIN main company
Sharemaestro market context Trend signal active 52 weeks +22.2% GAIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

eGain Corporation (EGAN) Stock Price, News, Quote & History

This page provides comprehensive financial information for eGain Corporation (EGAN), including its current stock price, recent news, historical data, and analyst insights. The company specializes in customer service infrastructure software solutions, offering products like eGain AI Agent and eGain AI Knowledge Hub. The stock …

EGAN main company
Sharemaestro market context Price below Trend Line 52 weeks +17.2% · Next-week setup positive 55.0% EGAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context